SOPHiA GENETICS™ is excited to be a part of the Association of Molecular Pathology annual meeting, Salt Lake City, Utah from November 15th-18th.
You will have the chance to chat with our experts and demo the universal SOPHiA DDM™ Platform.
Accelerating access to precision oncology data with decentralized MSK genomic solutions
Corporate Workshop Day, November 15
SOPHiA GENETICS is collaborating with Memorial Sloan Kettering Cancer Center (MSK) to decentralize their advanced precision oncology tools – MSK-ACCESS® for liquid biopsy and MSK-IMPACT® for comprehensive genomic profiling (CGP). By combining the clinical expertise of MSK in cancer genomics, the predictive algorithms of SOPHiA DDMTM, and the power of the global SOPHiA GENETICS network, experts hope to expand access to precision cancer analysis capabilities worldwide.
Presented by: Dr. Michael Berger – Co-director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology, MSK